Record results mark 16th consecutive quarter of revenue growth
Second Quarter Highlights:
-- Product revenues increase 26% to a record $47.6 million
-- A record 29,600 Masimo SET pulse oximeter units shipped
-- Net income of $10.6 million.$0.13 GAAP EPS / $0.19 Non-GAAP EPS
IRVINE, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion pulse oximetry, today announced its financial results for the quarter ended June 30, 2007, with product revenues of $47.6 million representing a 26% increase over $37.8 million for the second quarter of 2006. Including royalty revenues, Masimo reported total second quarter revenues of $63.7 million compared to $55.8 million for the second quarter of 2006. Net income for the quarter was $10.6 million, representing $0.13 GAAP or $0.19 non-GAAP earnings per common share.
Masimo also shipped a record 29,600 Masimo SET and Masimo Rainbow SET pulse oximeter units, excluding handheld pulse oximeters, during the second quarter of 2007, up from 23,700 in the comparable prior year period, resulting in an estimated worldwide installed base of 424,000 Masimo SET pulse oximeters.
For the quarter ended June 30, 2007, Masimo's net income was $10.6
million compared to $13.9 million for the same quarter in 2006. These
results reflect expected decreases in royalty revenue and interest income
resulting from the January 2006 patent litigation settlement and related
dividend distributions, as well as planned increases in research and
development, sales, marketing and general and administrative expenses to
support additional product d
|SOURCE Masimo Corporation|
Copyright©2007 PR Newswire.
All rights reserved